Genistein and a soy extract differentially affect three-dimensional bone parameters and bone-specific gene expression in ovariectomized mice.

Soy isoflavone preparations, such as purified genistein and a soy extract (Novasoy), were reported previously to exert beneficial effects on bones. Our purpose in this study was to compare the effects of genistein and Novasoy on 3-dimensional trabecular bone parameters and the expression of bone-specific genes in ovariectomized (OVX) mice. The sham-operated mice were fed the control diet and OVX mice were fed diets containing genistein or Novasoy or the control diet, with or without 17beta-estradiol treatment, for 5 wk. Trabecular bone parameters of tibias were measured by microcomputed tomography and gene expression was assayed by real-time PCR. Consumption of diets containing genistein or Novasoy partially prevented the ovariectomy-induced increase in body weight but did not alter the uterus weight of the OVX mice. Novasoy, but not purified genistein, significantly preserved trabecular bone mass, bone volume, and trabecular bone separation in the proximal tibial metaphysis. Purified genistein decreased mRNA expression of receptor activator of nuclear factor-kappaB ligand (RANKL), carbonic anhydrase II, and cathepsin K and enhanced the ratio of osteoprotegrin:RANKL mRNA expression in the tibial head of the OVX mice. In contrast, the diet containing Novasoy suppressed the OVX-induced increase in serum alkaline phosphatase but did not alter bone-specific gene expression of tibia. Our study demonstrated that a soy extract containing a similar level of genistein in the form of Novasoy is more effective than purified genistein in improving tibial trabecular bone quality in OVX mice, but the mechanism of action might be distinct from that of genistein.

[1]  A. Bitto,et al.  Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. , 2008, The Journal of clinical endocrinology and metabolism.

[2]  J. Penninger,et al.  RANK/RANKL: Regulators of Immune Responses and Bone Physiology , 2008, Annals of the New York Academy of Sciences.

[3]  K. Jeong,et al.  Soy extract is more potent than genistein on tumor growth inhibition. , 2008, Anticancer research.

[4]  A. Bitto,et al.  OPG and sRANKL Serum Concentrations in Osteopenic, Postmenopausal Women After 2‐Year Genistein Administration , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  E. Livne,et al.  Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo , 2008, Journal of cellular biochemistry.

[6]  W. Ward,et al.  Soy isoflavones and fatty acids: effects on bone tissue postovariectomy in mice. , 2007, Molecular nutrition & food research.

[7]  M. Lafage-Proust,et al.  Opposite effects of leptin on bone metabolism: a dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. , 2007, Endocrinology.

[8]  G. Gilani,et al.  Bioavailability of soy isoflavones in rats Part I: application of accurate methodology for studying the effects of gender and source of isoflavones. , 2007, Molecular nutrition & food research.

[9]  S. Uchiyama,et al.  Genistein and zinc synergistically stimulate apoptotic cell death and suppress RANKL signaling‐related gene expression in osteoclastic cells , 2007, Journal of cellular biochemistry.

[10]  N. Suzuki,et al.  Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. , 2007, Life sciences.

[11]  Chunfu Wu,et al.  Anti-osteoporotic effect of Erythrina variegata L. in ovariectomized rats. , 2007, Journal of ethnopharmacology.

[12]  U. Iwaniec,et al.  Strain‐Dependent Variations in the Response of Cancellous Bone to Ovariectomy in Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Y. Ju,et al.  Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations. , 2006, Carcinogenesis.

[14]  G. Degen,et al.  Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats. , 2006, Planta medica.

[15]  G. Vollmer,et al.  Effect of phytoestrogens on gene expression of carbonic anhydrase II in rat uterus and liver , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  S. Hirano,et al.  Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. , 2004, Toxicology.

[17]  Y. Ju,et al.  Soy processing influences growth of estrogen-dependent breast cancer tumors. , 2004, Carcinogenesis.

[18]  O. Ylikorkala,et al.  Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  S. Ho,et al.  Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. , 2003, The Journal of clinical endocrinology and metabolism.

[20]  S. Davis,et al.  Hormone replacement therapy: current controversies , 2003, Clinical endocrinology.

[21]  M. Payton,et al.  Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  R. Macdonald,et al.  Soy isoflavones increase latency of spontaneous mammary tumors in mice. , 2002, The Journal of nutrition.

[23]  Heidi D Nelson,et al.  Postmenopausal hormone replacement therapy: scientific review. , 2002, JAMA.

[24]  Jingping Liu,et al.  The diagnostic criteria for primary osteoporosis and the incidence of osteoporosis in China , 2002, Journal of Bone and Mineral Metabolism.

[25]  Y. Ju,et al.  Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. , 2001, The Journal of nutrition.

[26]  C. Loprinzi,et al.  Soy for breast cancer survivors: a critical review of the literature. , 2001, The Journal of nutrition.

[27]  S. Ho,et al.  Soy Intake and the Maintenance of Peak Bone Mass in Hong Kong Chinese Women , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  M. A. Bowman,et al.  A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. , 2001, Archives of internal medicine.

[29]  V. Coxam,et al.  Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. , 2001, The Journal of nutrition.

[30]  V. Coxam,et al.  Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. , 2000, The Journal of nutrition.

[31]  K. M. Chan,et al.  The prevalence of osteoporosis in the Hong Kong Chinese female population. , 1999, Maturitas.

[32]  Y. Ishimi,et al.  Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. , 1999, Endocrinology.

[33]  R. Turner Mice, Estrogen, and Postmenopausal Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  P. Lehenkari,et al.  Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. , 1998, Experimental cell research.

[35]  William L. Haskell,et al.  Potential Health Benefits of Dietary Phytoestrogens: A Review of the Clinical, Epidemiological, and Mechanistic Evidence1 , 1998 .

[36]  C D Gardner,et al.  Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. , 1998, The Journal of clinical endocrinology and metabolism.

[37]  P. Morris,et al.  The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats , 1998, Osteoporosis International.

[38]  W. Mazur,et al.  Phyto-oestrogens and Western diseases. , 1997, Annals of medicine.

[39]  B. Hollis,et al.  Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. , 1996, The Journal of nutrition.

[40]  R. Turner,et al.  The effect of long-term ovarian hormone deficiency on transforming growth factor-beta and bone matrix protein mRNA expression in rat femora. , 1994, Biochemical and biophysical research communications.

[41]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.